33924876|t|Resveratrol, Metabolic Dysregulation, and Alzheimer's Disease: Considerations for Neurogenerative Disease.
33924876|a|Alzheimer's disease (AD) has traditionally been discussed as a disease where serious cognitive decline is a result of Abeta-plaque accumulation, tau tangle formation, and neurodegeneration. Recently, it has been shown that metabolic dysregulation observed with insulin resistance and type-2 diabetes actively contributes to the progression of AD. One of the pathologies linking metabolic disease to AD is the release of inflammatory cytokines that contribute to the development of brain neuroinflammation and mitochondrial dysfunction, ultimately resulting in amyloid-beta peptide production and accumulation. Improving these metabolic impairments has been shown to be effective at reducing AD progression and improving cognitive function. The polyphenol resveratrol (RSV) improves peripheral metabolic disorders and may provide similar benefits centrally in the brain. RSV reduces inflammatory cytokine release, improves mitochondrial energetic function, and improves Abeta-peptide clearance by activating SIRT1 and AMPK. RSV has also been linked to improved cognitive function; however, the mechanisms of action are less defined. However, there is evidence to suggest that chronic RSV-driven AMPK activation may be detrimental to synaptic function and growth, which would directly impact cognition. This review will discuss the benefits and adverse effects of RSV on the brain, highlighting the major signaling pathways and some of the gaps surrounding the use of RSV as a treatment for AD.
33924876	0	11	Resveratrol	Chemical	MESH:D000077185
33924876	23	36	Dysregulation	Disease	MESH:D021081
33924876	42	61	Alzheimer's Disease	Disease	MESH:D000544
33924876	82	105	Neurogenerative Disease	Disease	MESH:D001750
33924876	107	126	Alzheimer's disease	Disease	MESH:D000544
33924876	128	130	AD	Disease	MESH:D000544
33924876	192	209	cognitive decline	Disease	MESH:D003072
33924876	225	230	Abeta	Gene	351
33924876	252	262	tau tangle	Disease	MESH:C536599
33924876	278	295	neurodegeneration	Disease	MESH:D019636
33924876	340	353	dysregulation	Disease	MESH:D021081
33924876	368	386	insulin resistance	Disease	MESH:D007333
33924876	391	406	type-2 diabetes	Disease	MESH:D003924
33924876	450	452	AD	Disease	MESH:D000544
33924876	485	502	metabolic disease	Disease	MESH:D008659
33924876	506	508	AD	Disease	MESH:D000544
33924876	527	539	inflammatory	Disease	MESH:D007249
33924876	594	611	neuroinflammation	Disease	MESH:D000090862
33924876	616	641	mitochondrial dysfunction	Disease	MESH:D028361
33924876	733	754	metabolic impairments	Disease	MESH:D008659
33924876	798	800	AD	Disease	MESH:D000544
33924876	862	873	resveratrol	Chemical	MESH:D000077185
33924876	875	878	RSV	Chemical	MESH:D000077185
33924876	900	919	metabolic disorders	Disease	MESH:D008659
33924876	977	980	RSV	Chemical	MESH:D000077185
33924876	989	1001	inflammatory	Disease	MESH:D007249
33924876	1076	1081	Abeta	Gene	351
33924876	1114	1119	SIRT1	Gene	23411
33924876	1124	1128	AMPK	Gene	5564
33924876	1130	1133	RSV	Chemical	MESH:D000077185
33924876	1290	1293	RSV	Chemical	MESH:D000077185
33924876	1301	1305	AMPK	Gene	5564
33924876	1469	1472	RSV	Chemical	MESH:D000077185
33924876	1573	1576	RSV	Chemical	MESH:D000077185
33924876	1596	1598	AD	Disease	MESH:D000544
33924876	Negative_Correlation	MESH:D000077185	MESH:D000544
33924876	Positive_Correlation	MESH:D000077185	23411
33924876	Positive_Correlation	MESH:D003072	351
33924876	Negative_Correlation	MESH:D000077185	MESH:D007249
33924876	Negative_Correlation	MESH:D000077185	MESH:D008659
33924876	Positive_Correlation	MESH:D000077185	5564
33924876	Negative_Correlation	MESH:D000077185	351

